Abliva AB (publ)

Abliva AB (publ)verified

NEVPF

Price:

$0.028

Market Cap:

$715.67M

Abliva AB (publ) develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in...[Read more]

Industry

Biotechnology

IPO Date

2014-03-20

Stock Exchange

OTC

Ticker

NEVPF

The Current Ratio as of November 2025 (TTM) for Abliva AB (publ) (NEVPF) is 4.13

According to Abliva AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 4.13. This represents a change of -25.78% compared to the average of 5.56 of the last 4 quarters.

Abliva AB (publ) (NEVPF) Historical Current Ratio (quarterly & annually)

How has NEVPF Current Ratio performed in the past?

The mean historical Current Ratio of Abliva AB (publ) over the last ten years is 4.29. The current 4.13 Current Ratio has changed 9.53% with respect to the historical average. Over the past ten years (40 quarters), NEVPF's Current Ratio was at its highest in in the March 2023 quarter at 17.74. The Current Ratio was at its lowest in in the March 2018 quarter at 1.29.

Quarterly (TTM)
Annual

Average

4.29

Median

3.96

Minimum

1.39

Maximum

7.88

Abliva AB (publ) (NEVPF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Abliva AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 465.15%

Maximum Annual Current Ratio = 7.88

Minimum Annual Increase = -77.46%

Minimum Annual Current Ratio = 1.39

Quarterly (TTM)
Annual
YearCurrent RatioChange
20244.138.57%
20233.80-51.79%
20227.88465.15%
20211.39-77.46%
20206.19109.96%
20192.9588.31%
20181.56-31.40%
20172.28-70.53%
20167.7456.63%
20154.94125.55%

Abliva AB (publ) (NEVPF) Average Current Ratio

How has NEVPF Current Ratio performed in the past?

The current Current Ratio of Abliva AB (publ) (NEVPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.27

5-year avg

4.68

10-year avg

4.29

Abliva AB (publ) (NEVPF) Current Ratio vs. Peers

How is NEVPF’s Current Ratio compared to its peers?

Abliva AB (publ)’s Current Ratio is less than Medivir AB (publ) (4.39), greater than Relief Therapeutics Holding AG (4.05), greater than Oncopeptides AB (publ) (3.42), less than Small Pharma Inc. (5.77), greater than Alpha Cognition Inc. (1.50), greater than IntelGenx Technologies Corp. (0.41), less than Herantis Pharma Oyj (8.10), greater than ImmuPharma plc (1.21), greater than Mindset Pharma Inc. (1.18), less than MedPeer,Inc. (5.53),

Build a custom stock screener for Abliva AB (publ) (NEVPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abliva AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abliva AB (publ) (NEVPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abliva AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Abliva AB (publ)'s Current Ratio?

How is the Current Ratio calculated for Abliva AB (publ) (NEVPF)?

What is the highest Current Ratio for Abliva AB (publ) (NEVPF)?

What is the 3-year average Current Ratio for Abliva AB (publ) (NEVPF)?

What is the 5-year average Current Ratio for Abliva AB (publ) (NEVPF)?

How does the current Current Ratio for Abliva AB (publ) (NEVPF) compare to its historical average?